Trial NCT02535247

View at ClinicalTrials.gov 
Org. Study IDs: HM-075

Last trial update was posted on 2022-07-08

MeSH Interventions

Pembrolizumab

MeSH Conditions

Lymphoma Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, T-Cell, Peripheral

Other Conditions


Stopping Reasons

Merck no longer providing drug for study

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID